The combination of naratriptan and prochlorperazine in migraine treatment.
Tietjen
Gretchen E
GE
Department of Neurology, Medical College of Ohio, 3120 Glendale Avenue, Toledo, OH 43614, USA.
Athanas
Kathy
K
Utley
Christine
C
Herial
Nabeel A
NA
Khuder
Sadik A
SA
D000328:Adult; D018492:Dopamine Antagonists / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy*; D010880:Piperidines / Q000627:therapeutic use*; D011346:Prochlorperazine / Q000627:therapeutic use*; D011446:Prospective Studies; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use*; D014363:Tryptamines
D018492:Dopamine Antagonists; D007211:Indoles; D010880:Piperidines; D017366:Serotonin Receptor Agonists; D014363:Tryptamines; C106783:naratriptan; D011346:Prochlorperazine